China vs United Kingdom: Prevalence rate of hypertension in men aged 30-79
China
30.2
in 2019
United Kingdom
29.9
in 2019
China rank
173rd
United Kingdom rank
175th
Prevalence rate of hypertension in men aged 30-79 over time
- China
- United Kingdom
How they compare
China currently reports 30.2 against 29.9 in United Kingdom, a difference of 0.3.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was United Kingdom ahead.
China ranks 173rd and United Kingdom ranks 175th of 195 countries.
United Kingdom has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 24.56 | 40.57 | 16.01 | United Kingdom |
| 2000s | 30.17 | 35.19 | 5.02 | United Kingdom |
| 2010s | 30.91 | 31.27 | 0.36 | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, China or United Kingdom?
- China, at 30.2 against 29.9 in United Kingdom as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between China and United Kingdom?
- 0.3, with China ahead.
- How many years of comparable data are there for China and United Kingdom?
- 30 years are reported by both, from 1990 to 2019.
- How do China and United Kingdom rank globally for prevalence rate of hypertension in men aged 30-79?
- China ranks 173rd and United Kingdom ranks 175th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.